Eiko LifeSciences Limited (BOM:540204)

India · Delayed Price · Currency is INR

45.38

-1.15 (-2.47%)

At close: Sep 4, 2026

Market Cap	651.01M -9.7%
Revenue (ttm)	587.44M +56.1%
Net Income	48.90M +84.6%
EPS	3.27 +64.4%
Shares Out	14.35M
PE Ratio	13.86
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	12,414
Open	47.30
Previous Close	46.53
Day's Range	44.82 - 47.30
52-Week Range	44.75 - 64.44
Beta	0.26
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 12, 2026

About Eiko LifeSciences

Eiko LifeSciences Limited, together with its subsidiary, manufactures and supplies specialty chemicals, fine chemicals, and active pharmaceutical ingredients in India and internationally. It offers speciality chemicals and intermediates, such as lasamide, trichloro salicylic acid, chloroacetyl xylidide, and thiodipropionic acid; agrochemical intermediates; and cosmetic emollients, including isopropyl oleate, isopropyl palmitate, methyl myristate, butyl laurate, isopropyl laurate, isopropyl myristate, butyl oleate, methyl myristate, and methyl l... [Read more]

Industry Industrial Organic Chemicals

Founded 1977

Employees 7

Stock Exchange Bombay Stock Exchange

Ticker Symbol 540204

Full Company Profile

Financial Performance

In fiscal year 2026, Eiko LifeSciences's revenue was 525.71 million, an increase of 39.58% compared to the previous year's 376.64 million. Earnings were 44.96 million, an increase of 113.53%.

Financial Statements